Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05959993
Other study ID # ODGayretli
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2020
Est. completion date July 7, 2022

Study information

Verified date July 2023
Source Ege University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the randomized controlled interventional study was to to evaluate the effect of human care model-based nursing interventions on psychosocial adaptation in patients with cardioverter defibrillator. A study was carried out on a sample of 64 patients who had been implanted with a defibrillator. The intervention group participants underwent six interviews at two-week intervals, during which a hybrid and structured nursing intervention was administered.


Description:

Aim: The aim of this research was to investigate the impact of nursing interventions that were Watson's Human Care Model- based nursing interventions on the psychosocial adjustment of patients who have undergone implantable cardioverter defibrillator (ICD) implantation. Design: The present study employs a randomized controlled design with a pretest-posttest control group, conducted over a period spanning from March 2020 to July 2022. Methods: The research was carried out utilizing an implantable cardioverter on individuals who met the inclusion criteria and provided consent to participate in the study at an adult cardiology outpatient unit located within a university hospital. A study was carried out on a sample of 64 patients who had been implanted with a defibrillator. The intervention group participants underwent six interviews at two-week intervals, during which a hybrid and structured nursing intervention was administered. The data were gathered utilizing an introductory information form and the Psychosocial Adjustment to Illness-Self-Report Scale (PAIS-SR). The statistical methods employed in the data analysis included the chi-square test, t test for independent groups, Mann-Whitney U test, t test for dependent groups, and Wilcoxon signed-rank test.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date July 7, 2022
Est. primary completion date January 23, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - the patient must be of legal age - the patient must have undergone ICD implantation at least one month prior - the patient must possess the ability to comprehend and communicate in Turkish - the patient must not exhibit any hearing or speech impairments - the patient must not have received a medical diagnosis of a neurological or psychiatric condition that may impact cognitive function, such as Alzheimer's or schizophrenia - the patient must possess the capability to operate a computer, telephone, and internet Exclusion Criteria: - the patient is less than 18 years old - the patient has hearing and speech problems - the patient must have received a medical diagnosis of a neurological or psychiatric condition that may impact cognitive function, such as Alzheimer's or schizophrenia - the patient must not possess the capability to operate a computer, telephone, and internet - the patient's refusal to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Human Care Model Based Nursing Interventions
The interviews scheduled for the intervention group were organized in accordance with the sub-dimensions of the PAIS-SR scale, and the content of each interview was informed by the 10 improvement processes of HCT.

Locations

Country Name City State
Turkey Ege University Izmir Bornova

Sponsors (1)

Lead Sponsor Collaborator
Ege University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Increasing the patient's psychosocial adjustment with ICD Psychosocial Adjustment to Illness Scale -Self Report (PAIS-SR) scale was used. This scale is a multidimensional scale that evaluates psychosocial adjustment to the disease. There are 7 different subscales of the scale that enable the determination of psychosocial adjustment, and the scale consists of a total of 46 items. These subscales are as follows; Orientation to Healthcare, Vocational Environment, Domestic Environment, Sexual Relationships, Extended family Relationships, Social Environment and Psychological distress. The minimum and maximum scores obtained from the scale are between 0-138. The higher the score, the worse the fit. Scores below 35 from the scale indicate good psychosocial adjustment, scores between 35-51 indicate moderately good psychosocial adjustment, and scores above 51 indicate poor adjustment. 10 week later
See also
  Status Clinical Trial Phase
Completed NCT04075253 - Acute Effect of One Single Bout of High Intensity Exercise on the Tendency for Ventricular Arrhythmia N/A
Completed NCT04070300 - Physical Activity and Ventricular Arrhythmias N/A
Completed NCT00522340 - Exercise After an ICD Phase 2
Completed NCT00157820 - DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study N/A
Active, not recruiting NCT01138670 - Complications Following Pacemaker or Implantable Defibrillator Cardioverter (ICD) Implantation in Denmark N/A
Completed NCT05366660 - Remote Programming of Cardiac Implantable Electronic Device N/A
Completed NCT01043562 - Precise Measurement of Pediatric Defibrillation Thresholds N/A
Terminated NCT01258283 - PET / CT With 18F-FDG: Does it Optimize the I 123-MIBG Imaging Results in the Search for Discriminating Factors for the Implementation of an Implantable Defibrillator? N/A
Completed NCT03579641 - Precision Event Monitoring for Patients With Heart Failure Using HeartLogic
Recruiting NCT03061747 - Multi-centre Observational Registry on Patients With Implantable Devices Remotely Monitored N/A
Completed NCT00498524 - Risk of Life-threatening Heart Rhythm Disturbances in Siblings N/A
Recruiting NCT00356239 - Implantable Cardioverter Defibrillators And Magnetic Resonance Imaging of the Heart at 1.5 Tesla N/A
Withdrawn NCT00507390 - Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia Phase 4
Completed NCT00598026 - Evaluation of the " Tele-follow-up " for the Follow-up of Implantable Defibrillators N/A
Completed NCT03271619 - Electrical Safety of Implantable Cardioverter Defibrillators N/A
Recruiting NCT06330675 - Correct Mobilization Time After CIED Implantation: A Single-centre, Open-label, Non-inferiority RCT N/A
Completed NCT00845390 - Patient Expectations After Implantable-cardioverter Defibrillator (ICD) Implantation
Recruiting NCT02882139 - International Electrical Storm Registry
Terminated NCT01097330 - Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia Phase 3